EUVIMEDEUVIMED entdecken
Crossref

Tabersonine Alleviates Cerebral Ischemia/Reperfusion Injury Partly via Repressing the SLC6A2 / NF ‐ κB Signalling Pathway

Li Zhang, Liji Chen, Juhua Chen, Xuehua Ge, Yingchun Yu, Panpan Sun, Yonglan Ruan iD

Clinical and Experimental Pharmacology and Physiology · 2026

DOI: 10.1111/1440-1681.70101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2026. Verfasst von Li Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Changzhou Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, China. Hauptthemen laut MEDLINE: Reperfusion Injury, NF-kappa B, Signal Transduction, Brain Ischemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aimed to investigate the neuroprotective functions and the underlying regulatory mechanisms of Tabersonine in cerebral ischemia/reperfusion (I/R) injury. Oxygen–glucose deprivation/reoxygenation (OGD/R)‐treated neural cells were used as a cell model under I/R context. Cell counting kit 8 (CCK8) assay and enzyme‐linked immunosorbent assay (ELISA) were used to assess the cell viability and the release levels of inflammatory cytokines (interleukin‐1β (IL‐1β), IL‐6 and tumour necrosis factor α (TNF‐α)) of treated neural cells. The apoptotic proportions of treated neural cells were analysed by flow cytometry, and the intracellular levels of reactive oxygen species (ROS) and superoxide dismutase (SOD) were quantified by corresponding kits. In this study, molecular docking analysis identified solute carrier family 6 member 2 (SLC6A2) as a potential target of Tabersonine in cerebral infarction, demonstrating a high binding affinity of −7.4 kcal/mol. Tabersonine treatment increased neural cell viability, repressed apoptosis and reduced the release levels of IL‐1β, IL‐6 and TNF‐α under OGD/R stress. Moreover, Tabersonine treatment reduced ROS levels and increased SOD expression in neural cells under OGD/R treatment. In contrast to the protective effect of SLC6A2 knockdown, its overexpression counteracted the neuroprotection conferred by Tabersonine. Tabersonine also inactivated the NF‐κB pathway partially via SLC6A2. Furthermore, Tabersonine pretreatment demonstrated significant neuroprotective effects in MCAO/R rats, as evidenced by reduced brain edema and attenuated neural inflammation and apoptosis. In conclusion, Tabersonine can alleviate neural impairment in cerebral I/R injury partially by inactivating the NF‐κB pathway through SLC6A2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryNF-kappa BSignal TransductionBrain IschemiaAnimalsRatsApoptosisNeuroprotective AgentsCell SurvivalRats, Sprague-DawleyReactive Oxygen SpeciesNeurons

Stichwörter der Autor:innen

NF‐κB signallingTabersoninecerebral ischemia/reperfusion injuryinflammationoxidative stress

Substanzen

NF-kappa BNeuroprotective AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Neurology, Changzhou Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, China.

ORCID-Profile: Yonglan Ruan

Förderung

  • National Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, L., Chen, L., Chen, J., Ge, X., Yu, Y., Sun, P., & Ruan, Y. (2026). Tabersonine Alleviates Cerebral Ischemia/Reperfusion Injury Partly via Repressing the SLC6A2 / NF ‐ κB Signalling Pathway. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70101

Vancouver

Zhang L, Chen L, Chen J, Ge X, Yu Y, Sun P, et al. Tabersonine Alleviates Cerebral Ischemia/Reperfusion Injury Partly via Repressing the SLC6A2 / NF ‐ κB Signalling Pathway. Clinical and Experimental Pharmacology and Physiology. 2026. doi:10.1111/1440-1681.70101

BibTeX
@article{Zhang2026,
  author = {Zhang, Li and Chen, Liji and Chen, Juhua and Ge, Xuehua and Yu, Yingchun and Sun, Panpan and Ruan, Yonglan},
  title = {Tabersonine Alleviates Cerebral Ischemia/Reperfusion Injury Partly via Repressing the SLC6A2 / NF ‐ κB Signalling Pathway},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2026},
  doi = {10.1111/1440-1681.70101}
}
Kostenlos starten →